Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer Electronic patient self-Reporting of Adverse ...
Abstract: To solve the time-optimal problem of velocity planning, various optimization-based methods were proposed in the literature, but these existing methods typically have limitations on ...
Abstract: An incremental iterative Q-learning algorithm (IIQLA) is proposed to tackle the optimal secure control problem for cyber-physical systems under false data injection attacks. Within a ...
Background Motor and cognitive dysfunctions are common and disabling features in multiple sclerosis (MS) that remain challenging to treat. Here, we aimed to explore the effect of exergames as a ...
The ORBITA-2 (Objective Randomized Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina) trial data demonstrate that, in patients with stable angina and ischemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results